Nick R. Lemoine
Scientific Advisory Board
Barts Cancer Institute, Queen Mary University of London & the Cancer Clinical Academic Unit at Barts Hospital, London UK
VCNBiosciences
Spain
Biography
Professor Lemoine is the Director of both the Barts Cancer Institute at Queen Mary University of London and the Cancer Clinical Academic Unit at Barts Hospital, having joined Barts and The London in April 2004. He also leads the Centre for Experimental Cancer Medicine, through which all clinical and translational studies are managed and supported. Currently there are over 120 studies open, and 600 patients are recruited into trials each year. He also leads laboratory programmes in oncolytic virotherapy and genomics of pancreatic cancer based in the Centre for Molecular Oncology & Imaging. Prof. Lemoine is also visiting Professor of Molecular Oncology at Zhengzhou University (China) from 2005, and is member of the Scientific Advisory Board of different biotech's including Valirx plc (from 2006), Medical Solutions plc, (from 2003), IC-Vec (from 2002), and Alexis Biotechnology Ltd (from 2001).
Research Interest
Oncology
